Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2000
05/31/2000EP1003723A1 2-acylaminopropanamines as tachykinin receptor antagonists
05/31/2000EP1003722A1 Crystalline 10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone and an improved process for preparing the same
05/31/2000EP1003721A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
05/31/2000EP1003712A1 Anthranilic acid analogs
05/31/2000EP1003706A1 Cyclohexenone long-chain alcohol and medicament containing same
05/31/2000EP1003546A1 Methods for treatment of patients afflicted wih multiple sclerosis using consensus interferon
05/31/2000EP1003544A1 C1q AND COLLECTIN RECEPTOR
05/31/2000EP1003542A1 Use of substances having oxytocin activity for preparation of medicaments for wound healing
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003518A1 A method for the treatment of mental illness in mammals and a composition therefor
05/31/2000EP1003517A1 Pharmaceutical composition for the treatment of so-called restless legs
05/31/2000EP1003510A1 Method for treating headache pain with topical local anesthetic compositions
05/31/2000EP1003509A1 Il-8 receptor antagonists
05/31/2000EP1003505A1 Heterocyclic vinylethers against neurological disorders
05/31/2000EP1003497A1 Il-8 receptor antagonists
05/31/2000EP1003495A1 Pharmaceutical compounds
05/31/2000EP1003494A1 (d)-METHADONE, A NONOPIOID ANALGESIC
05/31/2000EP1003491A1 Use of antagonists or partial agonists of the vanilloid receptor complexes for treating neurodegenerative diseases
05/31/2000EP1003489A1 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
05/31/2000EP1003486A2 Pharmaceutical compositions containing an effervescent acid-base couple
05/31/2000EP0868181B1 Use of alpha,alpha-diphenylacetic acid-4-(n-methyl-piperidyl)ester as anti-spasmodic
05/31/2000EP0865428B1 Vitamin d analogues
05/31/2000EP0862551B1 Fluoro-substituted benzoylpropionic acid derivatives
05/31/2000EP0794942B1 Substituted biphenyl compounds for the treatment of inflammation
05/31/2000EP0747033B1 Transfusion liquid-containing holder and prepared transfusion liquid
05/31/2000EP0689440B1 Use of triazine compounds as anxiolytics
05/31/2000DE19856475A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs
05/31/2000CN1255141A Salts of 5 'alpha'-pregn-16-en-3 'beta'-ol-20-one 3-sulphate ester with progestin activity
05/31/2000CN1255136A Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
05/31/2000CN1255131A Amidine derivatives as inhibitors of nitric oxide synthase
05/31/2000CN1255130A Compounds
05/31/2000CN1255124A Substituted isoquinoline derivatives and their use as anticonulsants
05/31/2000CN1255117A Excitatory amino acid receptor modulators
05/31/2000CN1255065A Medicinal preparation containing lipophilicity inert gas
05/31/2000CN1254713A Agarofuran derivatives, their preparing process, medicinal composition containing them and their medicinal usage
05/31/2000CN1254572A Drug-dropping tablet and its preparing process
05/31/2000CN1254571A Drug-dropping cigarette and its preparing process
05/31/2000CN1254570A Drug-dropping capsule and its preparing process
05/31/2000CN1254569A Drug-dropping syrup and its preparing process
05/31/2000CN1254564A Oral liquid for preventing and curing senile dementia
05/31/2000CN1052905C Cynanchum otophyllum for anti-Meniere's disease, usage and preparation method
05/31/2000CN1052896C Ningshen medicinal composition for anti-psychosis
05/31/2000CN1052895C Ningshen medicinal composition for curing psychasthenia disease
05/31/2000CN1052890C Chinese proprietary medicine for curing headache and trigeminal neualagia
05/31/2000CN1052888C Preparation for sobering up and preventing drunkenness and preparing method thereof
05/31/2000CN1052885C Chinese medicine herbs for giving off drug of opium
05/31/2000CN1052880C Method for preparation capsule for treating angioneurotic headache
05/30/2000US6069165 Administering to the patient suffering from dysthymia, psychoses, paranoid and productive schizophrenias, acute delirous psychoses, an effective amount of amisulpride or salts
05/30/2000US6069162 Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
05/30/2000US6069152 Nervous system disorders; cardiovascular disorders; gastrointestinal disorders
05/30/2000US6069138 Use of phospholipids of animal origin in therapy and/or dietetics
05/30/2000US6068999 Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
05/30/2000CA2223360C Cyclic peptide compounds and their production process
05/30/2000CA2159326C Method for treating amyloidosis
05/30/2000CA2144407C Biodegradable polymer matrices for sustained delivery of local anesthetic agents
05/30/2000CA2014645C Pharmaceutical compounds
05/30/2000CA2004747C Substituted phenylpyrimidines useful in the treatment of cns disorders
05/30/2000CA2002472C Liquid oral formulation
05/25/2000WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000WO2000029601A1 A method for depopulating of vertebrate testis and for generation of transgenic species
05/25/2000WO2000029583A2 Immunoglobulin superfamily proteins
05/25/2000WO2000029577A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
05/25/2000WO2000029574A2 Inflammation-associated genes
05/25/2000WO2000029570A1 Novel protein and utilization thereof
05/25/2000WO2000029569A1 Methods of diagnosing or treating neurological diseases
05/25/2000WO2000029564A2 Human glycine transporter type 2
05/25/2000WO2000029551A2 Cells, culture methods, and their use in autologous transplantation therapy
05/25/2000WO2000029550A2 Low oxygen culturing of central nervous system progenitor cells
05/25/2000WO2000029549A2 Low oxygen culturing of cells
05/25/2000WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029412A1 PENTAAZA-CYCLOPENTA[A]NAPHTHALENE DERIVATIVES AS LIGANDS FOR GABAA α5 RECEPTORS
05/25/2000WO2000029405A1 Method for preparing (2s)-1-[ (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl] pyrrolidine-2- carboxamide
05/25/2000WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/25/2000WO2000029397A1 New piperazine and piperidine compounds
05/25/2000WO2000029384A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
05/25/2000WO2000029381A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors
05/25/2000WO2000029371A1 Excitatory amino acid receptor modulators
05/25/2000WO2000029023A1 Cox-2 inhibitors in combination with nmda-blockers for treating pain
05/25/2000WO2000028992A1 Riluzole and alpha-tocopherol combination
05/25/2000WO2000028981A2 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor
05/25/2000WO2000028980A2 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain
05/25/2000WO2000016797A3 Use of glp-1 or analogs in treatment of stroke
05/25/2000WO2000015798A3 Mammalian transforming growth factor beta - 9 (ztgfss9)
05/25/2000WO2000000825A9 Detection and modulation of cellular immunity to immune privileged antigens
05/25/2000DE19854147A1 Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative
05/25/2000DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases
05/25/2000CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000CA2351551A1 Low oxygen culturing of cells
05/25/2000CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000CA2351224A1 Cox-2 inhibitors in combination with nmda-blockers for treating pain
05/25/2000CA2350785A1 31 human secreted proteins
05/25/2000CA2350698A1 Human glycine transporter type 2
05/25/2000CA2350532A1 Excitatory amino acid receptor modulators
05/25/2000CA2350531A1 Method for treating pain
05/25/2000CA2350443A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors
05/25/2000CA2350420A1 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor
05/25/2000CA2350415A1 Inflammation-associated genes
1 ... 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 ... 1833